Human papilloma virus (HPV) and p53 immunostaining in advanced tonsillar carcinoma--relation to radiotherapy response and survival

MLA

Signe Friesland, et al. “Human Papilloma Virus (HPV) and P53 Immunostaining in Advanced Tonsillar Carcinoma--Relation to Radiotherapy Response and Survival.” Anticancer Research, vol. 21, no. 1B, Apr. 2001. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid.dedup....2a640ef86bfc3179b8ee1a32f4d48d11&authtype=sso&custid=ns315887.

APA

Signe Friesland, Mellin H, Munck-Wikland E, Nilsson A, Lindholm J, Dalianis T, & Lewensohn R. (2001). Human papilloma virus (HPV) and p53 immunostaining in advanced tonsillar carcinoma--relation to radiotherapy response and survival. Anticancer Research, 21(1B).

Chicago

Signe Friesland, Mellin H, Munck-Wikland E, Nilsson A, Lindholm J, Dalianis T, and Lewensohn R. 2001. “Human Papilloma Virus (HPV) and P53 Immunostaining in Advanced Tonsillar Carcinoma--Relation to Radiotherapy Response and Survival.” Anticancer Research 21 (1B). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid.dedup....2a640ef86bfc3179b8ee1a32f4d48d11&authtype=sso&custid=ns315887.